Hotel Dieu de France Hospital

Beirut BP166830

0 studies enrolling now · 11 studies all time

What they study most

Atrial Fibrillation, Cardiac Disease, Crohn's Disease, Deep Vein Thrombosis (DVT), First Line Non-Small Cell Lung Cancer, Multiple Sclerosis, Primary Sjogrens Disease, Pulmonary Embolism, Stroke, Ulcerative Colitis, Venous Thromboembolism (VTE), Von Willebrand Diseases

Studies at this site

• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease — Stopped early
• A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome — Running, not enrolling
• Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis — Running, not enrolling
• Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE) — Completed
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment — Completed
• Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWD — Completed
• Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis — Completed
• Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease — Completed
• GLORIA-AF Registry Program - Second and Third Phases — Completed